Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease

Authors:
  • HLHe Li
    He Li
  • ASAndrew D. Strand
    Andrew D. Strand
  • BWBen Woodman
    Ben Woodman
  • KSKirupa Sathasivam
    Kirupa Sathasivam
  • SLShi-Hua Li
    Shi-Hua Li
  • SGShabnam Ghazi-Noori
    Shabnam Ghazi-Noori
  • EHEmma Hockly
    Emma Hockly
  • SFSyed M.N.N. Faruque
    Syed M.N.N. Faruque
  • JCJang-Ho J. Cha
    Jang-Ho J. Cha

Abstract
In postmortem Huntington's disease brains, mutant htt is present in both nuclear and cytoplasmic compartments. To dissect the impact of nuclear and extranuclear mutant htt on the initiation and progression of disease, we generated a series of transgenic mouse lines in which nuclear localization or nuclear export signal sequences have been placed N-terminal to the htt exon 1 protein carrying 144 glutamines. Our data indicate that the exon 1 mutant protein is present in the nucleus as part of an oligomeric or aggregation complex. Increasing the concentration of the mutant transprotein in the nucleus is sufficient for and dramatically accelerates the onset and progression of behavioral phenotypes. Furthermore, nuclear exon 1 mutant protein is sufficient to induce cytoplasmic neurodegeneration and transcriptional dysregulation. However, our data suggest that cytoplasmic mutant exon 1 htt, if present, contributes to disease progression.

This publication has 42 references indexed in Scilit: